XML 20 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
EARNINGS PER SHARE
9 Months Ended
Sep. 30, 2018
EARNINGS PER SHARE  
EARNINGS PER SHARE

2. EARNINGS PER SHARE

Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) No. 260‑10‑45 addresses whether instruments granted in share-based payment transactions are participating securities prior to vesting and, therefore, need to be included in the earnings allocation in computing earnings per share (“EPS”). The restricted stock awards and certain restricted stock units granted by the Company contain non-forfeitable rights to dividends and therefore are considered participating securities. The two-class method for calculating basic EPS excludes dividends paid to participating securities and any undistributed earnings attributable to participating securities.

The following table presents the computation of EPS for the three and nine months ended September 30, 2018 and 2017:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30, 

 

September 30, 

(In thousands, except per share data)

    

2018

    

2017

    

2018

    

2017

Net income

 

$

6,547

 

$

9,443

 

$

25,363

 

$

27,455

Dividends paid on and earnings allocated to participating securities

 

 

(145)

  

 

(197)

 

 

(550)

 

 

(557)

Income attributable to common stock

 

$

6,402

 

$

9,246

 

$

24,813

 

$

26,898

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding, including participating securities

 

 

19,890

  

 

19,793

 

 

19,869

 

 

19,748

Weighted average participating securities

 

 

(438)

  

 

(412)

 

 

(435)

 

 

(405)

Weighted average common shares outstanding

 

 

19,452

  

 

19,381

 

 

19,434

 

 

19,343

Basic earnings per common share

 

$

0.33

 

$

0.48

 

$

1.28

 

$

1.39

 

 

 

 

 

 

 

 

 

 

 

 

 

Income attributable to common stock

 

$

6,402

 

$

9,246

 

$

24,813

 

$

26,898

Impact of assumed conversions - interest on 8.5% trust preferred securities

 

 

 —

  

 

 —

 

 

 —

 

 

32

Income attributable to common stock including assumed conversions

 

$

6,402

 

$

9,246

 

$

24,813

 

$

26,930

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

19,452

  

 

19,381

 

 

19,434

 

 

19,343

Incremental shares from assumed conversions of options and restricted stock units

 

 

33

  

 

25

 

 

27

 

 

21

Incremental shares from assumed conversions of 8.5% trust preferred securities

 

 

 —

  

 

 —

 

 

 —

 

 

23

Weighted average common and equivalent shares outstanding

 

 

19,485

  

 

19,406

 

 

19,461

 

 

19,387

Diluted earnings per common share

 

$

0.33

 

$

0.48

 

$

1.28

 

$

1.39

 

There were 47,393 stock options outstanding at September 30, 2018 that were not included in the computation of diluted earnings per share for the three and nine months ended September 30, 2018 because the options' exercise prices were greater than the average market price of common stock and were, therefore, antidilutive. There were no stock options outstanding at September 30, 2017.

There were no restricted stock units that were antidilutive for the three months ended September 30, 2018 and 2017. There were 21,980 restricted stock units that were antidilutive for the nine months ended September 30, 2018 and no restricted stock units that were antidilutive for the nine months ended September 30, 2017.

The $15.7 million in trust preferred securities outstanding at December 31, 2016 were redeemed effective January 18, 2017 and therefore were not included in the computation of diluted earnings per share for the three months ended September 30, 2017, but were dilutive for the nine months ended September 30, 2017 and therefore were included in the computation of diluted earnings per share for that period.